• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向人类转录因子 TEAD 的新型别构效应物。

Novel Allosteric Effectors Targeting Human Transcription Factor TEAD.

机构信息

Department of Chemistry, Center for Research Computing, Center for Drug Discovery, Design, and Delivery (CD4), Southern Methodist University, Dallas, TX 75205, USA.

Graduate Program in Computational and Data Sciences, Schmid College of Science and Technology, Chapman University, Orange, CA 92866, USA.

出版信息

Int J Mol Sci. 2023 May 19;24(10):9009. doi: 10.3390/ijms24109009.

DOI:10.3390/ijms24109009
PMID:37240355
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10219411/
Abstract

The Hippo pathway is an evolutionary conserved signaling network involved in several cellular regulatory processes. Dephosphorylation and overexpression of Yes-associated proteins (YAPs) in the Hippo-off state are common in several types of solid tumors. YAP overexpression results in its nuclear translocation and interaction with transcriptional enhanced associate domain 1-4 (TEAD1-4) transcription factors. Covalent and non-covalent inhibitors have been developed to target several interaction sites between TEAD and YAP. The most targeted and effective site for these developed inhibitors is the palmitate-binding pocket in the TEAD1-4 proteins. Screening of a DNA-encoded library against the TEAD central pocket was performed experimentally to identify six new allosteric inhibitors. Inspired by the structure of the TED-347 inhibitor, chemical modification was performed on the original inhibitors by replacing secondary methyl amide with a chloromethyl ketone moiety. Various computational tools, including molecular dynamics, free energy perturbation, and Markov state model analysis, were employed to study the effect of ligand binding on the protein conformational space. Four of the six modified ligands were associated with enhanced allosteric communication between the TEAD4 and YAP1 domains indicated by the relative free energy perturbation to original molecules. Phe229, Thr332, Ile374, and Ile395 residues were revealed to be essential for the effective binding of the inhibitors.

摘要

Hippo 通路是一个进化上保守的信号网络,参与多种细胞调节过程。在 Hippo 失活状态下,Yes 相关蛋白(YAP)的去磷酸化和过表达在几种实体肿瘤中很常见。YAP 的过表达导致其核转位,并与转录增强相关域 1-4(TEAD1-4)转录因子相互作用。已经开发了共价和非共价抑制剂来针对 TEAD 和 YAP 之间的几个相互作用位点。这些开发的抑制剂最针对和有效的位点是 TEAD1-4 蛋白中的棕榈酸结合口袋。通过实验对 TEAD 中心口袋进行 DNA 编码文库筛选,以鉴定六种新的别构抑制剂。受 TED-347 抑制剂结构的启发,对原始抑制剂进行了化学修饰,用氯甲基酮取代二级甲基酰胺。使用各种计算工具,包括分子动力学、自由能扰动和 Markov 状态模型分析,研究配体结合对蛋白质构象空间的影响。在六种修饰的配体中,有四种与 TEAD4 和 YAP1 结构域之间增强的别构通讯相关,这是通过对原始分子的相对自由能扰动来表示的。揭示了 Phe229、Thr332、Ile374 和 Ile395 残基对于抑制剂的有效结合是必不可少的。

相似文献

1
Novel Allosteric Effectors Targeting Human Transcription Factor TEAD.靶向人类转录因子 TEAD 的新型别构效应物。
Int J Mol Sci. 2023 May 19;24(10):9009. doi: 10.3390/ijms24109009.
2
Small-Molecule Covalent Modification of Conserved Cysteine Leads to Allosteric Inhibition of the TEAD⋅Yap Protein-Protein Interaction.小分子共价修饰保守半胱氨酸导致 TEAD⋅Yap 蛋白-蛋白相互作用的别构抑制。
Cell Chem Biol. 2019 Mar 21;26(3):378-389.e13. doi: 10.1016/j.chembiol.2018.11.010. Epub 2018 Dec 20.
3
Structure-Based Design of Y-Shaped Covalent TEAD Inhibitors.基于结构的 Y 型共价 TEAD 抑制剂设计。
J Med Chem. 2023 Apr 13;66(7):4617-4632. doi: 10.1021/acs.jmedchem.2c01548. Epub 2023 Mar 22.
4
Computational design and experimental confirmation of a disulfide-stapled YAP helix-trap derived from TEAD4 helical hairpin to selectively capture YAP α1-helix with potent antitumor activity.基于 TEAD4 螺旋发夹设计的 YAP 螺旋夹的计算设计和实验验证,可选择性捕获具有强抗肿瘤活性的 YAPα1-螺旋。
J Comput Aided Mol Des. 2024 Aug 23;38(1):31. doi: 10.1007/s10822-024-00572-2.
5
Effect of the acylation of TEAD4 on its interaction with co-activators YAP and TAZ.TEAD4的酰化对其与共激活因子YAP和TAZ相互作用的影响。
Protein Sci. 2017 Dec;26(12):2399-2409. doi: 10.1002/pro.3312. Epub 2017 Nov 11.
6
A Non-canonical Role of YAP/TEAD Is Required for Activation of Estrogen-Regulated Enhancers in Breast Cancer.YAP/TEAD 的非经典作用对于乳腺癌中雌激素调节增强子的激活是必需的。
Mol Cell. 2019 Aug 22;75(4):791-806.e8. doi: 10.1016/j.molcel.2019.06.010. Epub 2019 Jul 11.
7
The interaction of TEA domain transcription factor 4 (TEAD4) and Yes-associated protein 1 (YAP1) promoted the malignant process mediated by serum/glucocorticoid regulated kinase 1 (SGK1).TEA 结构域转录因子 4(TEAD4)和 Yes 相关蛋白 1(YAP1)的相互作用促进了血清/糖皮质激素调节激酶 1(SGK1)介导的恶性进程。
Bioengineered. 2021 Dec;12(1):601-614. doi: 10.1080/21655979.2021.1882142.
8
Leveraging the Fragment Molecular Orbital and MM-GBSA Methods in Virtual Screening for the Discovery of Novel Non-Covalent Inhibitors Targeting the TEAD Lipid Binding Pocket.利用碎片分子轨道和 MM-GBSA 方法在虚拟筛选中发现针对 TEAD 脂质结合口袋的新型非共价抑制剂。
Int J Mol Sci. 2024 May 14;25(10):5358. doi: 10.3390/ijms25105358.
9
Activation of Hepatocyte Growth Factor/MET Signaling as a Mechanism of Acquired Resistance to a Novel YAP1/TEAD Small Molecule Inhibitor.肝细胞生长因子/ MET 信号的激活作为新型 YAP1/TEAD 小分子抑制剂获得性耐药的机制。
Mol Cancer Ther. 2024 Aug 1;23(8):1095-1108. doi: 10.1158/1535-7163.MCT-23-0538.
10
Structural and ligand-binding analysis of the YAP-binding domain of transcription factor TEAD4.转录因子 TEAD4 的 YAP 结合域的结构和配体结合分析。
Biochem J. 2018 Jun 26;475(12):2043-2055. doi: 10.1042/BCJ20180225.

引用本文的文献

1
DNA-encoded library screening uncovers potent DNMT2 inhibitors targeting a cryptic allosteric binding site.DNA编码文库筛选发现了靶向隐秘变构结合位点的强效DNMT2抑制剂。
iScience. 2025 Aug 5;28(9):113300. doi: 10.1016/j.isci.2025.113300. eCollection 2025 Sep 19.
2
Exploring purine analogues as inhibitors against Katanin, a microtubule severing enzyme using molecular modeling approach.利用分子建模方法探索嘌呤类似物作为微管切断酶katanin的抑制剂。
Sci Rep. 2024 Dec 30;14(1):32095. doi: 10.1038/s41598-024-83723-7.
3
Understanding the impact of binding free energy and kinetics calculations in modern drug discovery.

本文引用的文献

1
Prioritizing Small Sets of Molecules for Synthesis through in-silico Tools: A Comparison of Common Ranking Methods.通过计算机工具对小分子集合进行优先级排序用于合成:常用排序方法比较。
ChemMedChem. 2023 Jan 3;18(1):e202200425. doi: 10.1002/cmdc.202200425. Epub 2022 Nov 29.
2
Homology modeling of Forkhead box protein C2: identification of potential inhibitors using ligand and structure-based virtual screening.FOXC2 同源建模:基于配体和结构的虚拟筛选鉴定潜在抑制剂。
Mol Divers. 2023 Aug;27(4):1661-1674. doi: 10.1007/s11030-022-10519-0. Epub 2022 Sep 1.
3
Computational investigation of peptidomimetics as potential inhibitors of SARS-CoV-2 spike protein.
理解结合自由能和动力学计算在现代药物发现中的影响。
Expert Opin Drug Discov. 2024 Jun;19(6):671-682. doi: 10.1080/17460441.2024.2349149. Epub 2024 May 9.
作为严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白潜在抑制剂的拟肽的计算研究。
J Biomol Struct Dyn. 2023 Sep-Oct;41(15):7144-7157. doi: 10.1080/07391102.2022.2116601. Epub 2022 Aug 29.
4
Dynamics of hydrogen bonds in the secondary structures of allosteric protein phototropin 1.变构蛋白向光素1二级结构中氢键的动力学
Comput Struct Biotechnol J. 2021 Dec 7;20:50-64. doi: 10.1016/j.csbj.2021.11.038. eCollection 2022.
5
Recent Therapeutic Approaches to Modulate the Hippo Pathway in Oncology and Regenerative Medicine.近期调节肿瘤学和再生医学中 Hippo 通路的治疗方法。
Cells. 2021 Oct 11;10(10):2715. doi: 10.3390/cells10102715.
6
DNA-Encoded Chemical Libraries: A Comprehensive Review with Succesful Stories and Future Challenges.DNA编码化学文库:成功案例与未来挑战的全面综述
ACS Pharmacol Transl Sci. 2021 Jun 14;4(4):1265-1279. doi: 10.1021/acsptsci.1c00118. eCollection 2021 Aug 13.
7
A Benchmark of Electrostatic Method Performance in Relative Binding Free Energy Calculations.静电方法在相对结合自由能计算中的性能基准。
J Chem Inf Model. 2021 Mar 22;61(3):1048-1052. doi: 10.1021/acs.jcim.0c01424. Epub 2021 Mar 9.
8
Exploring TEAD2 as a drug target for therapeutic intervention of cancer: A multi-computational case study.探讨 TEAD2 作为癌症治疗干预的药物靶点:一项多计算案例研究。
Brief Bioinform. 2021 Sep 2;22(5). doi: 10.1093/bib/bbab007.
9
Targeting the YAP-TEAD interaction interface for therapeutic intervention in glioblastoma.针对胶质母细胞瘤中 YAP-TEAD 相互作用界面的治疗干预。
J Neurooncol. 2021 Apr;152(2):217-231. doi: 10.1007/s11060-021-03699-6. Epub 2021 Jan 28.
10
The novel potent TEAD inhibitor, K-975, inhibits YAP1/TAZ-TEAD protein-protein interactions and exerts an anti-tumor effect on malignant pleural mesothelioma.新型强效TEAD抑制剂K-975可抑制YAP1/TAZ-TEAD蛋白-蛋白相互作用,并对恶性胸膜间皮瘤发挥抗肿瘤作用。
Am J Cancer Res. 2020 Dec 1;10(12):4399-4415. eCollection 2020.